James Richard Porter, the President and CEO of $NUVL, sold 800 shares of the company on 02-18-2025 for an estimated $63,208. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.3% of their shares of this class of stock. Following this trade, they now own 249,062 shares of this class of $NUVL stock.
$NUVL Insider Trading Activity
$NUVL insiders have traded $NUVL stock on the open market 106 times in the past 6 months. Of those trades, 0 have been purchases and 106 have been sales.
Here’s a breakdown of recent trading of $NUVL stock by insiders over the last 6 months:
- JAMES E FLYNN has made 0 purchases and 2 sales selling 2,000,000 shares for an estimated $195,500,000.
- ANDREW A. F. HACK sold 1,250,000 shares for an estimated $110,000,000
- JAMES RICHARD PORTER (President and CEO) has made 0 purchases and 17 sales selling 152,301 shares for an estimated $13,023,261.
- HENRY E. PELISH (Chief Scientific Officer) has made 0 purchases and 14 sales selling 45,778 shares for an estimated $4,335,333.
- ALEXANDRA BALCOM (Chief Financial Officer) has made 0 purchases and 16 sales selling 44,016 shares for an estimated $4,022,797.
- DEBORAH ANN MILLER (Chief Legal Officer) has made 0 purchases and 15 sales selling 24,964 shares for an estimated $2,207,966.
- DARLENE NOCI (Chief Development Officer) has made 0 purchases and 15 sales selling 19,016 shares for an estimated $1,693,854.
- MATTHEW SHAIR has made 0 purchases and 22 sales selling 12,000 shares for an estimated $1,083,465.
- CHRISTOPHER DURANT TURNER (Chief Medical Officer) has made 0 purchases and 3 sales selling 4,016 shares for an estimated $320,009.
- EMILY CONLEY sold 3,334 shares for an estimated $283,456
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NUVL Hedge Fund Activity
We have seen 130 institutional investors add shares of $NUVL stock to their portfolio, and 93 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) removed 2,000,000 shares (-10.0%) from their portfolio in Q4 2024, for an estimated $156,560,000
- BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC removed 1,250,000 shares (-46.3%) from their portfolio in Q4 2024, for an estimated $97,850,000
- COMMODORE CAPITAL LP added 681,600 shares (+72.5%) to their portfolio in Q4 2024, for an estimated $53,355,648
- VESTAL POINT CAPITAL, LP added 600,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $46,968,000
- POLAR CAPITAL HOLDINGS PLC added 584,223 shares (+161.2%) to their portfolio in Q4 2024, for an estimated $45,732,976
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 400,000 shares (+142.9%) to their portfolio in Q4 2024, for an estimated $31,312,000
- FAIRMOUNT FUNDS MANAGEMENT LLC removed 369,400 shares (-21.9%) from their portfolio in Q4 2024, for an estimated $28,916,632
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.